this instance. unlike in many other areas of toxicology. Additional laboratories may well have similar packed-column capacity which can be put to use in this way. Dr Smith emphasises, as we did, the importance of resolving the phenylboronate derivatives of propylene and ethylene glycols and we submit that partial resolution is acceptable, since both compounds are unlikely to be present in the same sample. We felt it prudent to point out that peakbroadening might occur with the direct injection assay if injection volumes greater than 3 ilL were used since 3-5 III volumes are common in packed column work. We fail to see why this should be thought of as indicative of a problem with the assay as described. Similarly, the fact that we drew attention to the possibility of 'carry-over' of ethylene glycol cannot be said to render the procedure 'inadequate'. the more so since we pointed out that acidification of the derivatising reagent eliminated the circumstances under which such carry-over had been observed. We note that Dr Smith I reported degradation of baseline stability. peak shape, and peak quantitation after each batch of analyses when using his method; injections of 5-10 III water and elevation of the column temperature to 28(fC for 15-20 min were required to restore column performance.
Determination of pH, PCO z ; PO z , sodium and potassium in the same whole blood sample I have read the letters of Swaminathan;' Mann and Green" and the articles by Shek and Swaminatharr'
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and Mann and Green." While I do not doubt the results reported by these authors, I do not believe the findings justify the conclusion that a blood gas specimen is unsuitable for sodium and potassium analysis.
I agree that liquid heparin in excess of that normally contained in the dead space may be accidentally left in a blood gas syringe and that the problem is exacerbated if the syringe is not filled with blood. In such cases, however, problems may be encountered with pH, PC0 2 and P0 2 determinations as described by Hutchinson et al. 5 as well as with sodium and potassium.
Most clinical chemists accept that the quality of results for any analysis are limited by the quality of sample collected. It is the responsibility of the laboratory director working with the medical staff to ensure that the correct type and quantity of anticoagulant is used for each analyte. Blood-gas collection syringes containing appropriate quantities of Iyophilised lithium heparin are commercially available and suitable for blood gas, sodium and potassium measurements on the same sample.
The conclusion in the two letters': 3 is particularly unfortunate since instrumentation is now available to measure simultaneously pH, PC0 2 • P0 2 , sodium and potassium in blood, thus reducing capital, supplies and labour costs when these determinations are requested together. Saeeningfor morphine/heroin abuse with the Toxi-Lab system
GRAHAM WIDDOWSON
Contrary to the report of Nadkarni et al. I we have found the Toxi-Lab system to be sensitive to free morphine in spiked urine samples at concentrations of between I and 2 i1WmL at all four stages of the routine screening procedure. This level of sensitivity was also attained using the manufacturer's recommended silver nitrate confirmation procedure. By concentrating the sample onto two discs instead of one, little extra cost is incurred with the latter confirmation test, with no apparent loss of sensitivity.
Although there have been reports of false positives for morphine': 3 with the haemagglutination test (BCL, Lewes, UK) we have experienced incidences of false negatives, and what could be described as lack of sensitivity to opiates at concentrations in excess of the lower levels of sensitivity quoted by the manufacturers. The problem was first noticed when some samples giving strong positive results for morphine on a routine Toxi-Lab screen were found to be negative with the haemagglutination test. An independent laboratory confirmed these results. The problem recurred with another batch of tubes a short time later. The manfacturcrs did eventually admit that there was a problem, and, after a considerable time delay, replaced the faulty batches free of charge.
In the absence of RIA or EMIT methods for opiates in our laboratory, and because of the unreliability of the haemagglutination test we now perform glucuronide hydrolysis on all samples from possible heroin addicts. Although extra costs arc incurred, we suggest that hydrolysis of the sample followed by a Toxi-Lab screen and/or silver nitrate confirmation test should always be carried out if morphine/heroin abuse is suspected. The author replies as follows:
S SLIM, P BARNES and L ALLEN
In spite of the results of Slim et 01 in finding morphine at 1-2 I1g mL-1 at all four stages of the Toxi-Lab procedure it is still our view that we need to use a more sensitive method, as well as the TLC procedure, for the detection of morphine. We regard Toxi-Lab as an excellent procedure for differentiating between different drugs, and opiates in particular, but we now also use an EMIT technique routinely when we look for morphine.
ALASTAIR HAY Department of Chemical Pathology.
Old Medical School. London LS2 9JT. UK Do serum fructosamine levels accurately ret1ect levels of glycated albumin? I am not convinced that serum glycated albumin (GSA) is poorly correlated with serum fructosamine levels as indicated in the article by Winocour et al. I My main concern is that they express GSA levels as percentage of albumin and compare these against fructosamine levels which are expressed in concentrations units. Moreover, in their unit for GSA, albumin concentration is implicitly incorporated, whilst in the fructosamine unit albumin concentration is not taken into account. This can confound a correlation, especially if one takes into consideration that samples with so-called albumin levels that fall within the reference range (for our laboratory 35-55 giL) can mean a variation in albumin levels of up to 57%. To apply this to a GSA level of 6% can produce a calculated concentration value of 2·1 giL for GSA in a specimen with an albumin concentration of 35 giL or of 3 giL if the albumin level was 50 giL. This difference is quite significant! Accordingly, the authors have not shown the real correlation between GSA and fructosamine for their data and it would be unwise to speculate on the possible difference between these two measurements of long-term diabetic control using their results as presented.
